Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rituximab
•
IVIG
•
General Rheumatology
•
Allergy & Immunology
•
Primary Immunodeficiency
How do you time concurrent therapy with rituximab and IVIG?
Related Questions
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
Are there specific conventional DMARDs and/or biologics that are contraindicated in patients with alpha-gal allergy?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
Do you continue TNF inhibitors in patients with a new diagnosis of CLL?
